6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Purity ≥98.0% (HPLC) Favipiravir Intermediate COVID-19

Incazelo emfushane:

Igama Lekhemikhali: 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile

6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile

I-CAS: 356783-31-8

Ukubukeka: Okuphuzi Okuphaphathekile kuya Kuphuphu Olumhlophe

Ubumsulwa: ≥98.0% (HPLC)

I-Intermediate ye-Favipiravir (CAS: 259793-96-9) ekwelapheni ukutheleleka ngegciwane loMkhuhlane kanye ne-COVID-19

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile
Omqondofana 6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile
Inombolo ye-CAS 356783-31-8
Inombolo yeCAT I-RF-API294
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu
I-Molecular Formula I-C5H2FN3O
Isisindo samangqamuzana 139.09
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Ephuzi Okuphaphathekile ukuya kokumhlophe
Ukuhlonza IR, HPLC
Umswakama (KF) ≤1.0%
Izinsalela ekushiseni ≤0.50%
Ukungcola Okukodwa ≤1.0%
Ukungcola Okuphelele ≤2.0%
Izinsimbi Ezisindayo ≤20ppm
Ubumsulwa ≥98.0% (nge-HPLC)
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Favipiravir (CAS 259793-96-9);I-Antiviral;I-COVID 19

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) iyi-Intermediate ye-Favipiravir (CAS 259793-96-9).I-Favipiravir umuthi omusha we-antiviral obanzi oqondiswe ku-RNA polymerase (RdRp) encike ku-RNA.I-Favipiravir yasungulwa ngasekupheleni kweminyaka yawo-1990 yinkampani eyathengwa kamuva inkampani yaseJapan i-Fujifilm njengengxenye yoshintsho isuka ebhizinisini lezithombe iye ekunakekelweni kwezempilo.Ngemva kokuhlolwa ngokumelene nohlu lwamagciwane, umuthi wagunyazwa e-Japan ngo-2014 ukuze usetshenziswe ezimeni eziphuthumayo ngokumelene nezifo eziwumshayabhuqe noma ukwelapha izinhlobo ezintsha zomkhuhlane.Ngesikhathi kuqubuka i-coronavirus entsha, imiphumela yocwaningo lomtholampilo lweSigaba I somuthi olwanyatheliswa ngoMashi 2020 lwabonisa ukuthi umuthi ungaba nomthelela wokusheshisa ukusulwa kwegciwane ukuze unciphise ukuqhubeka kwenyumoniya entsha ye-coronavirus.I-Favipiravir ingasetshenziswa ekwelapheni iziguli ezine-COVID-19 ezinconywe yi-WHO.Kusulwe yi-Drugs Controller General of India (DCGI) ukuze kusetshenziswe "imikhawulo ephuthumayo" phakathi kweziguli ze-COVID-19.

Bhala umyalezo wakho lapha futhi usithumelele wona